Records containing: Pachyonychia Congenita
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-03Epidermal Growth Factor Receptor Inhibition for Keratinopathies
-
CLINICAL_TRIALS study record update · 2025-01-15Phase 1b, Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of a 1% Topical Formulation of KM-001 for the Treatment of Type I Punctate Palmoplantar Keratoderma or Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2025-01-07Phase I, Open Label Study Designed to Evaluate the Safety and Efficacy of a 1% Topical Formulation of KM-001 in the Treatment of Type I Punctate Palmoplantar Keratoderma or Pachyonychia Congenital Diseases
-
CLINICAL_TRIALS study record update · 2024-08-29A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2024-08-29A Multicenter, Four-Part, Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in the Treatment of Adults With Moderate to Severe Pachyonychia Congenita
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2024-08-29VALO-2: A Multicenter, Phase 3b, Open-Label Treatment Extension Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2022-12-09A Multicenter Open-Label Treatment Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2018-11-21International Pachyonychia Congenita Research Registry
-
CLINICAL_TRIALS study record update · 2017-12-06Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
-
CLINICAL_TRIALS study record update · 2016-10-07Phase 1b Clinical Trial Using Topical Sirolimus for the Treatment of Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2011-06-27Simvastatin Treatment of Pachyonychia Congenita
-
CLINICAL_TRIALS study record update · 2008-11-19A Single-Center, Placebo-Controlled, Rising Dose to Tolerance and Safety Study of TD101, an siRNA Designed for Treatment of Pachyonychia Congenita